Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Yehuda Handelsman MD, FACP, FNLA, FASPC, FAHA, MACE

Yehuda Handelsman MD, FACP, FNLA, FASPC, FAHA, MACE

Medical Director & Principal Investigator, Metabolic Institute of America; Chair, Scientific Advisory Board, DCMi- Diabetes, CardioRenal & Metabolism Institute; Chair & Program Director, Annual World Congress on IR, DM & CVD & Heart in Diabetes, Tarzana, California

Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE, is an endocrinologist in private practice and Medical Director & Principal Investigator of the Metabolic Institute of America. Chair Scientific Advisory Board: Diabetes, CardioRenal & Metabolism Institute- DCMi a Think Tank. He is a nationally and internationally recognized authority on Diabetes, Lipids, Obesity, and its complications. A Master of American College of Endocrinology, Fellow American Heart Association, American Society of Preventive Cardiology, National lipid Association and American College of Physicians. Chair & program director Annual World Congress on Insulin Resistance, Diabetes and CVD and Heart in Diabetes Medical Congress. Chair, DCRM- “Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. Chair & Editor the International Lipid Forum. Past president American College of Endocrinology, American Association of Clinical Endocrinologists and Pacific Lipid Association. Chaired AACE/ACE Guidelines, algorithms & Consensuses on Diabetes & technology, Lipids, Obesity, lipodystrophy, Insulin Resistance and Cardiometabolic syndrome. He published over 150 peer reviewed original manuscripts and books’ chapters. Associate and guest editor of several medical journals His Book “Clinical Management of Cardiovascular Risk in Diabetes and Obesity” publisher Professional Communications.”  Handelsman has been listed repeatedly in "America best Physicians", “The Leading Physicians of the world”, “Top Doctors of Los Angeles,” “Southern California Super Doctors,” and “Best Doctors of America.”


Dr. Handelsman reports the following:

Research grants, consultant & speaker honoraria- Amgen, Applied Therapeutic, AZ, Bayer, BI, Corcept, Esperion, Ionis, Lilly, Mankind, Merck, Merck-Pfizer, Novartis, Novo Nordisk, Regor, Sanofi.